12 Health Care Stocks Moving In Tuesday's Intraday Session
Portfolio Pulse from Benzinga Insights
Several healthcare stocks experienced significant price movements during Tuesday's intraday session. Adial Pharmaceuticals, CytoMed Therapeutics, Eloxx Pharmaceuticals, Biodexa Pharmaceuticals, Freeline Therapeutics, and Nanoviricides saw their stock prices increase, while Journey Medical, Nutriband, BioRestorative Therapies, Viridian Therapeutics, Sientra, and Enzo Biochem experienced declines.
July 11, 2023 | 5:37 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Adial Pharmaceuticals stock increased by 114.8% to $0.43.
The significant increase in Adial Pharmaceuticals' stock price is likely to have a positive impact on its short-term performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Biodexa Pharmaceuticals shares moved upwards by 59.19% to $6.75.
The substantial rise in Biodexa Pharmaceuticals' stock price is expected to positively affect its short-term performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Eloxx Pharmaceuticals stock rose 104.34% to $7.99.
The significant increase in Eloxx Pharmaceuticals' stock price is likely to have a positive impact on its short-term performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Freeline Therapeutics stock moved upwards by 40.37% to $3.86.
The significant increase in Freeline Therapeutics' stock price is likely to have a positive impact on its short-term performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
CytoMed Therapeutics stock increased by 104.38% to $7.13.
The substantial rise in CytoMed Therapeutics' stock price is expected to positively affect its short-term performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Nanoviricides shares increased by 26.95% to $1.79.
The substantial rise in Nanoviricides' stock price is expected to positively affect its short-term performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
BioRestorative Therapies stock decreased by 14.89% to $3.03.
The significant decrease in BioRestorative Therapies' stock price is likely to have a negative impact on its short-term performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Journey Medical stock declined by 25.7% to $2.11.
The significant decrease in Journey Medical's stock price is likely to have a negative impact on its short-term performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Enzo Biochem shares declined by 10.44% to $1.63.
The substantial drop in Enzo Biochem's stock price is expected to negatively affect its short-term performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Nutriband shares declined by 16.24% to $2.6.
The substantial drop in Nutriband's stock price is expected to negatively affect its short-term performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Sientra stock fell 11.61% to $3.96.
The significant decrease in Sientra's stock price is likely to have a negative impact on its short-term performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Viridian Therapeutics shares declined by 14.77% to $20.9.
The substantial drop in Viridian Therapeutics' stock price is expected to negatively affect its short-term performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100